NitroMed

NitroMed nitric oxide-based therapeutics, including the controversial heart failure therapeutic , BiDil, which is marketed exclusively to African Americans.

History:

Formerly located in Bedford, MA. NitroMed was acquired by Deerfield Management in 2009.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
704.941.2020
Email: info@nitromed.com

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics:Clinical late (III)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: